Cuvitru
Payments companies reported to CMS as associated with Cuvitru. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cuvitru, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cuvitru
These are the largest totals companies reported as associated with Cuvitru. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Todd Hrabak | Glendale, AZ | Allergy | $50,816.95 |
| Kenneth Paris | New Orleans, LA | Allergy & Immunology | $38,559.18 |
| Nathanael Brady | Colorado Springs, CO | Allergy | $32,622.98 |
| Raffi Tachdjian | Santa Monica, CA | Allergy & Immunology | $30,750.03 |
| Leman Yel | Orange, CA | Adolescent Medicine (Internal Medicine) | $29,835.00 |
| Usha Chandrahasa | Port Charlotte, FL | Allergy & Immunology | $28,516.02 |
| James Fernandez | Cleveland, OH | Allergy & Immunology | $27,174.06 |
| Nicholas Hartog | Grand Rapids, MI | Allergy & Immunology | $26,801.55 |
| Jordan Orange | New York, NY | Pediatric Allergy/Immunology | $26,199.94 |
| Lukena Karkhanis | San Antonio, TX | Allergy & Immunology | $23,903.06 |
Prescribed Cuvitru?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.